Okada Purifying Therapy in combination with duloxetine vs. duloxetine alone in patients with TMD and fibromyalgia: a randomized clinical study.

Gianluca BrutiManuela Ramos AtencioAnna D'UrsoPaola Di GiacomoCarlo Di Paolo

Published in: Journal of complementary & integrative medicine (2020)

The additional complementary treatment (OPT) did not appear to give the patients with TMDs and FM any further benefit but it might improve pharmacological tolerability of the traditional medication.

Keyphrases

healthcare
open label
double blind
clinical trial
emergency department
replacement therapy
bone marrow
mesenchymal stem cells
cell therapy
study protocol